- Treatment of persistent pulmonary hypertension of the newborn (PPHN) refractory to treatment with inhaled nitric oxide
- IV intermittent infusion
- Loading dose: over 3 hours
- IV continuous infusion
- PO: Dilute in small amount of water or feeds
IV
Load: 0.4 mg/kg over 3 hours followed by a continuous infusion
Continuous infusion: 1.6 mg/kg/day
PO
0.5 - 2 mg/kg/dose Q6h (maximum: 2 mg/kg/dose PO Q4h)
- CVS: hypotension, tachycardia
- Dermatologic: rash
- GI: diarrhea, dyspepsia
- BP, HR
- IV formulation may be administered at a concentration of 0.8 mg/mL undiluted
- Solution Compatible : D5W
- A 10 mg dose of the injection is predicted to have an effect equal to a 20 mg oral dose taking into consideration the parent drug and active metabolite
- Steinhorn RH, Kinsella JP, Pierce C, et al. Intravenous Sildenafil in The Treatment of Neonates with Persistent Pulmonary Hypertension. J Pediatr 2009; 155: 841-7
-Baquero H, Soliz A, Neira F, Veneqas ME, Sola A. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 2006; 117: 1077-83
-Herrea J, Castillo R, Concha E, Soliz A. Oral sildenafil treatment as an alternative to inhaled NO therapy for persistent pulmonary hypertension of the newborn. In: E-PAS 2006: 59: 3724.3
-Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook 20th Edition. Hudson: Lexi-Comp Inc.; 2013
- Chen J, Lau E (Editors). Drug Handbook and Formulary - The Hospital for Sick Children 2013-14. Toronto: Lexi-Comp Inc; 2013